{
    "name": "flutemetamol F 18",
    "comment": "Rx",
    "other_names": [
        "Vizamyl"
    ],
    "classes": [
        "Diagnostic Imaging Agents"
    ],
    "source": "https://reference.medscape.com/drug/Vizamyl-flutemetamol-f-18-999888",
    "pregnancy": {
        "common": [
            "There are no available data on use in pregnant women to evaluate for a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes",
            "All radiopharmaceuticals, have potential to cause fetal harm depending on stage of fetal development, and magnitude of radiopharmaceutical dose",
            "If considering administration to a pregnant woman, inform patient about potential for adverse pregnancy outcomes based on radiation dose from drug and gestational timing of exposure"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "There are no data on presence of drug or metabolites in human milk or effects on breastfed infant or milk production",
            "Exposure to a breastfed infant can be minimized by temporary discontinuation of breastfeeding",
            "The developmental and health benefits of breastfeeding should be considered along with mother’s clinical need for therapy and any potential adverse effects on breastfed child from drug or from underlying maternal condition",
            "To decrease radiation exposure to breastfed infant, advise a lactating woman to interrupt breastfeeding, and pump and discard breast milk for 24 hours after administration of drug"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Contraindicated in patients with a history of hypersensitivity reaction, polysorbate 80, or any other inactive ingredient"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Hypersensitivity reactions (eg, flushing and dyspnea) have been observed within minutes following administration; these reactions may occur in patients with no history of prior exposure",
                "Before initiating therapy, ask patients about prior reactions to drugs, especially those containing polysorbate",
                "Resuscitation equipment and trained personnel should be immediately available"
            ],
            "specific": [
                {
                    "type": "Risk for image misinterpretation",
                    "description": [
                        "Errors may occur in the estimation of brain neuritic plaque density during image interpretation; perform image interpretation independently of the patient’s clinical information",
                        "Other errors may be due to extensive brain atrophy that limits the ability to distinguish gray and white matter on the scan as well as motion artifacts that distort the image"
                    ]
                },
                {
                    "type": "Radiation risk",
                    "description": [
                        "Similar to other radiopharmaceuticals, flutemetamol F 18 contributes to a patient’s overall long-term cumulative radiation exposure; long-term cumulative radiation exposure is associated with an increased risk of cancer",
                        "Ensure safe handling to protect patients and health care workers from unintentional radiation exposure"
                    ]
                }
            ]
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Flushing",
            "percent": "2"
        },
        {
            "name": "Increased blood pressure",
            "percent": "2"
        },
        {
            "name": "Headache",
            "percent": "1"
        },
        {
            "name": "Nausea",
            "percent": "1"
        },
        {
            "name": "Dizziness",
            "percent": "1"
        }
    ]
}